Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]

C. L. Harper-Wynne, K. Sumpter, Christopher Ryan, K. Priest, A. Norton, P. Ross, H. E R Ford, P. Johnson, M. E R O'Brien

Research output: Contribution to journal › Article

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)289-290
Number of pages2
JournalLung Cancer
Volume47
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Cite this

Harper-Wynne, C. L., Sumpter, K., Ryan, C., Priest, K., Norton, A., Ross, P., ... O'Brien, M. E. R. (2005). Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]. Lung Cancer, 47(2), 289-290. https://doi.org/10.1016/j.lungcan.2004.08.013

Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]. / Harper-Wynne, C. L.; Sumpter, K.; Ryan, Christopher; Priest, K.; Norton, A.; Ross, P.; Ford, H. E R; Johnson, P.; O'Brien, M. E R.

In: Lung Cancer, Vol. 47, No. 2, 02.2005, p. 289-290.

Research output: Contribution to journal › Article

Harper-Wynne, CL, Sumpter, K, Ryan, C, Priest, K, Norton, A, Ross, P, Ford, HER, Johnson, P & O'Brien, MER 2005, 'Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]', Lung Cancer, vol. 47, no. 2, pp. 289-290. https://doi.org/10.1016/j.lungcan.2004.08.013
Harper-Wynne CL, Sumpter K, Ryan C, Priest K, Norton A, Ross P et al. Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]. Lung Cancer. 2005 Feb;47(2):289-290. https://doi.org/10.1016/j.lungcan.2004.08.013
Harper-Wynne, C. L. ; Sumpter, K. ; Ryan, Christopher ; Priest, K. ; Norton, A. ; Ross, P. ; Ford, H. E R ; Johnson, P. ; O'Brien, M. E R. / Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]. In: Lung Cancer. 2005 ; Vol. 47, No. 2. pp. 289-290.
@article{c2f169d45e7848539c670c4003e61484,
title = "Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]",
author = "Harper-Wynne, {C. L.} and K. Sumpter and Christopher Ryan and K. Priest and A. Norton and P. Ross and Ford, {H. E R} and P. Johnson and O'Brien, {M. E R}",
year = "2005",
month = "2",
doi = "10.1016/j.lungcan.2004.08.013",
language = "English (US)",
volume = "47",
pages = "289--290",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control [1]

AU - Harper-Wynne, C. L.

AU - Sumpter, K.

AU - Ryan, Christopher

AU - Priest, K.

AU - Norton, A.

AU - Ross, P.

AU - Ford, H. E R

AU - Johnson, P.

AU - O'Brien, M. E R

PY - 2005/2

Y1 - 2005/2

UR - http://www.scopus.com/inward/record.url?scp=11444268632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11444268632&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2004.08.013

DO - 10.1016/j.lungcan.2004.08.013

M3 - Article

C2 - 15639729

AN - SCOPUS:11444268632

VL - 47

SP - 289

EP - 290

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -

Access to Document